Active Ingredient(s):Carteolol FDA Approved: * December 28, 1988 Pharm Company: *ABBOTT Category:Vision / Eye Health
Carteolol is a non-selective beta blocker used to treat glaucoma.
It has been found to act as a serotonin 5-HT1A and 5-HT1B receptor antagonist in addition to being a beta blocker.
It was patented in 1972 and approved for medical use in 1980.
Brand names include Cartrol, Ocupress, Teoptic, Arteolol, Arteoptic, Calte, Cartéabak, Carteol, Cartéol, Cartrol, Elebloc, Endak, Glauteolol, Mikelan, Poenglaucol, and Singlauc.
* May have multiple approval dates, manufacturers, or labelers. 1 Discussion